Longevity
CJC-1295 and Ipamorelin: What the 'GH Stack' Really Does
CJC-1295 and ipamorelin are sold together as an anti-ageing growth-hormone stack. Here's the honest science — clever design, real human data, but unapproved and unproven for ageing.
In the anti-ageing and bodybuilding corners of the internet, CJC-1295 and ipamorelin are almost never mentioned apart. They're sold as a pair — "the GH stack" — promising leaner muscle, deeper sleep, faster recovery and a more youthful body by nudging your own glands to make more growth hormone. What's interesting about this particular pair is that, unlike most peptides we write about, the core mechanism is genuinely well-documented in humans. The catch is everything that gets claimed after the mechanism. This is the close-up companion to our broader guide to growth-hormone peptides.
What are CJC-1295 and ipamorelin?
Both are synthetic peptides, but they work through two different doors to the same room. Your growth hormone is released from the pituitary gland, and the body controls it with two opposing signals: GHRH (which says "release") and somatostatin (which says "stop"), with the hunger hormone ghrelin also able to trigger a release.
- CJC-1295 is a long-acting analog of GHRH — it imitates the body's own "release growth hormone" signal, but lasts far longer than natural GHRH 1. (You'll see "CJC-1295 with DAC" and "without DAC / mod GRF 1-29"; the DAC version is engineered to linger in the blood for days.)
- Ipamorelin is a ghrelin mimic — it pulls the separate ghrelin lever to prompt a growth-hormone pulse. Its claim to fame is selectivity: in the original animal work it raised growth hormone without the spikes in cortisol and prolactin that older, cruder secretagogues caused 2.
Why are they stacked together?
This is the genuinely clever part, and it's real pharmacology, not marketing. CJC-1295 and ipamorelin push on two different pathways at once — the GHRH door and the ghrelin door. Pulling both levers together produces a larger, cleaner pulse of growth hormone than either peptide alone, while ipamorelin's selectivity keeps the hormonal "noise" down. The design makes sense on paper, and the individual pieces are backed by human and animal data 12.
So do they work?
It depends entirely on what you mean by "work".
At raising growth hormone and IGF-1? Yes — and that's well established. In healthy adults, CJC-1295 produced sustained, dose-dependent increases in growth hormone and IGF-1 lasting days from a single injection 1. Ipamorelin reliably triggers growth-hormone release with a cleaner hormonal profile than older secretagogues 2. On the narrow question of "do these peptides move the hormone", the answer is genuinely yes.
At making you healthier, leaner or younger? That's the leap — and it's not proven. The entire anti-ageing pitch rests on an unstated assumption: that more growth hormone is good for you. But raising a hormone is not the same as improving an outcome. There are no large, long-term trials showing that CJC-1295/ipamorelin makes healthy adults live longer, stay leaner over time, or age more slowly. The mechanism is real; the benefit is borrowed on faith.
The uncomfortable longevity twist
Here's the part the anti-ageing marketing tends to leave out. If you look across the biology of ageing, the relationship between growth hormone and lifespan is the opposite of the intuitive one. In many animal models, the longest-lived individuals have lower growth-hormone and IGF-1 signalling, not higher — reduced activity in this pathway is one of the more reproducible ways to extend lifespan in the lab. This is part of the wider science we cover in the hallmarks of ageing. It doesn't prove these peptides are harmful, but it should make anyone pause before assuming that cranking up growth hormone is an obvious anti-ageing win. At minimum, the picture is far less settled than "more GH = more youth" implies.
What about approval and safety?
This is where these two land in the same place as the rest of the category:
- Not approved for anti-ageing or muscle building. Of the growth-hormone-related peptides, only tesamorelin is FDA-approved, and only for a specific HIV-related condition — as we explain in the hub article. CJC-1295 and ipamorelin are used off-label or sold as unregulated "research" peptides 3.
- No established safe long-term dose, and grey-market vials carry the usual unknown purity and sterility problems common to peptides bought online.
- Banned in sport. Both sit on anti-doping prohibited lists as growth-hormone secretagogues — a real risk for any tested athlete.
- Plausible biological cautions. Sustained higher growth hormone and IGF-1 can affect insulin sensitivity and fluid balance, and the long-term effects of years of artificially raised IGF-1 simply haven't been studied in healthy people.
What we see at the clinic
People usually ask about this stack after reading that it's a "natural" way to boost growth hormone — the word "natural" doing a lot of quiet work, since you're still injecting a synthetic peptide to override a system your body deliberately winds down with age. We try to separate the two questions: yes, these peptides really do raise growth hormone; no, that doesn't mean raising it makes a healthy person healthier or younger, and the evidence for that simply isn't there. For most people chasing energy, body composition and better ageing, the durable gains come from the basics of healthy ageing and, where genuinely indicated, properly monitored hormone care like testosterone where it's low — not from self-administering an unapproved peptide on the assumption that more of a declining hormone must be better.
Common questions
Do CJC-1295 and ipamorelin actually raise growth hormone? Yes — that part is well supported by human and animal pharmacology studies 12. The open question is whether doing so produces the health and anti-ageing benefits that are claimed.
Is the "GH stack" approved or legal? Neither peptide is approved for anti-ageing or muscle building. They're used off-label or sold as unregulated research chemicals, and both are banned in sport.
Is more growth hormone good for ageing? Not obviously. In animal models, lower growth-hormone signalling often tracks with longer life — the reverse of the marketing assumption. It's an unsettled question, not a solved one.
What's the difference between CJC-1295 "with" and "without DAC"? DAC (drug affinity complex) makes CJC-1295 last for days rather than minutes; "without DAC" (mod GRF 1-29) is short-acting. Both are unapproved; the difference is duration, not safety or proof.
Key takeaway
CJC-1295 and ipamorelin are unusual among "research" peptides in that the core mechanism is real and human-documented: they genuinely raise your own growth hormone, and the two-pathway stack is cleverly designed. But raising a hormone is not the same as improving health, and there's no good evidence the stack makes people leaner, younger or longer-lived — while the broader biology of ageing actually complicates the "more is better" story. Add in the lack of approval, unknown long-term safety and grey-market sourcing, and the honest verdict is: interesting pharmacology, unproven promise. Treat the confident anti-ageing claims with the scepticism they've earned.
Sources
- Ionescu M. & Frohman L.A., J Clin Endocrinol Metab (2006) — Once-daily administration of CJC-1295, a long-acting GHRH analog, in healthy adults (human study, PubMed)
- Raun K. et al., European Journal of Endocrinology (1998) — Ipamorelin, the first selective growth hormone secretagogue (PubMed)
- Wang L. et al., Signal Transduction and Targeted Therapy (2022) — Therapeutic peptides: current applications and future directions (Nature)
For general information and education only — not medical advice. Read our disclaimer.